Cargando…
COVID-19 and Cardiovascular Diseases: Challenges and Solutions
Rampantly spreading around the globe and taking thousands of lives each day, coronavirus disease 2019 (COVID-19) may present with varied cardiovascular manifestations. Those with evidence of myocardial injury have a worse prognosis too. Patients with pre-existing cardiovascular diseases or risk fact...
Autores principales: | Sharma, Prachi, Pradhan, Akshyaya, Vohra, Shweta, Sethi, Rishi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139746/ https://www.ncbi.nlm.nih.gov/pubmed/34046108 http://dx.doi.org/10.14740/cr1244 |
Ejemplares similares
-
Eplerenone: The Multifaceted Drug in Cardiovascular Pharmacology
por: Pradhan, Akshyaya, et al.
Publicado: (2020) -
Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure
por: Pradhan, Akshyaya, et al.
Publicado: (2019) -
Ezetimibe and Improving Cardiovascular Outcomes: Current Evidence and Perspectives
por: Pradhan, Akshyaya, et al.
Publicado: (2020) -
Snake in right coronary artery—Extensive spontaneous coronary artery dissection in a young male
por: Vohra, Shweta, et al.
Publicado: (2022) -
Silent giant left atrium: A case report
por: Vohra, Shweta, et al.
Publicado: (2022)